Reproductive Medicine

Clinical evidence, research, and medical intelligence in Reproductive Medicine.

Egg Freezing and the Fertility Industry’s Feminist Failures

A physician’s egg-freezing experience raises broader concerns about how the fertility industry markets autonomy while women absorb the costs and pressure.

By Dr. A. Nikhil Krishnan, MBBS · Oct 28, 2026 · 5 min read

Reproductive Medicine·BMJ Open

Assisted Reproduction Linked to Modestly Higher Perinatal Hospitalisation Risk

UK record-linkage data found modestly higher perinatal hospitalisations after assisted reproduction versus population controls, with sibling analyses weakening…

Oct 25, 2026

Reproductive Medicine·BMJ Open

Infertility Management Recommendations Address Evidence Gaps and Clinical Variation

Consensus recommendations for infertility care review evidence through June 2019 and call for better trials amid major practice…

Oct 23, 2026

Reproductive Medicine·Front Immunol

F3 and F7 Polymorphisms Linked to IVF Failure in Uzbek Women

Uzbek case-control data linked F3 and F7 variants with prior IVF failure and found higher ongoing pregnancy after…

Oct 23, 2026

Reproductive Medicine·Cancer Cell

S-adenosylmethionine Improves Sperm DNA Damage via Transsulfuration Pathway

Cell Press reports that S-adenosylmethionine may improve spermatogenic dysfunction and sperm DNA damage through the transsulfuration pathway.

Oct 22, 2026

Reproductive Medicine·Med News Today

Infertility Causes in Men and Women: Diagnosis, Risks, and Treatment

Infertility can stem from ovulation disorders, sperm problems, hormonal imbalance, structural disease, or prior treatment affecting reproductive function.

Oct 22, 2026

Reproductive Medicine·Brain

Reddit IVF add-ons often amplify unsupported benefit claims

A Reddit analysis found most IVF add-on claims and recommendations favored use, while many benefit claims lacked support…

Oct 19, 2026

Reproductive Medicine

Clinical evidence, research, and medical intelligence in Reproductive Medicine.

In Brief The 5-minute rounds

New hypertension guideline lowers the treatment threshold to 130/80 mm Hg.
Phase 3 GLP-1 trial reports a 20% cut in major adverse cardiac events.
FDA clears a next-generation CAR-T therapy for relapsed lymphoma.
Meta-analysis links early mobilisation to shorter ICU length of stay.
Rapid guidance broadens empiric antibiotics for suspected sepsis.